Nutex Health NUTX
$162.64 +$0.54 (+0.33%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $162.64 0.00%
Open$158.62
Prev close$162.10
Day range$155.04 – $165.79
Volume157.5K
Market cap$1.12B
P/E (TTM)7.0
Dividend yield–
Earnings
Average move on report day±17.8%last 10 reports
Closed higher7 of 1070% of the time
Best reaction+51.8%
Worst reaction-16.4%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q3 | 5 Nov 2026 | After Market | – | -6.75% | – |
| 2026/Q2 | 6 Aug 2026 | After Market | – | +6.67% | – |
| 2026/Q1 | 30 Apr 2026 | After Market | – | +17.09% | – |
| 2025/Q4 | 5 Mar 2026 | After Market | – | -14.30% | – |
| 2025/Q2 | 14 Aug 2025 | After Market | – | -16.40% | – |
| 2025/Q1 | 13 May 2025 | After Market | – | +26.10% | – |
| 2024/Q4 | 31 Mar 2025 | After Market | – | +51.82% | – |
| 2024/Q3 | 7 Nov 2024 | After Market | – | +9.24% | – |
| 2024/Q2 | 8 Aug 2024 | After Market | – | +27.85% | – |
| 2024/Q1 | 8 May 2024 | After Market | – | +2.01% | – |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Where the revenue comes from
Quarter 2026/Q3
By business line
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$217.61M-18.7% YoY
Operating profit$77.10M-40.9% YoY
Net profit$57.34M-40.8% YoY
Diluted EPS$5.71-26.4% YoY
Free cash flow$73.14M-26.3% YoY
Operating cash flow$78.35M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin47.8%
Operating margin39.0%
Net margin20.7%
Return on equity43.8%
Return on assets16.5%
Return on invested capital24.4%
Current ratio4.76
Liabilities / assets47.6%
Cash & investments$249.91M
Total debt$355.89M
Net cash (debt)-$105.98M
Free cash flow / sales31.1%
No comments yet — be the first to weigh in on NUTX.
Sign in to join the discussion.